Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Exelixis (EXEL)
NASDAQ:EXEL
EXEL Analyst Ratings
Moderate Buy
12 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
EXEL Stock 12 Month Forecast
Average Price Target
$37.47
▲(6.78% Upside)
| Highest Price Target$45.00 | Average Price Target$37.47 | Lowest Price Target$29.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
Reiterated
02/18/25
H.C. Wainwright
Reiterated
02/13/25
Stifel Nicolaus
Reiterated
02/12/25
Morgan Stanley
Reiterated
02/12/25
Piper Sandler
Reiterated
02/12/25
JMP Securities
Reiterated
02/12/25
Truist Financial
Reiterated
02/12/25
BMO Capital
Reiterated
02/11/25
Guggenheim
Reiterated
02/11/25
RBC Capital
$38
Buy
8.29%
Upside
Reiterated
02/11/25
RBC Capital Reaffirms Their Buy Rating on Exelixis (EXEL)
TD Cowen
$34→$38
Buy
8.29%
Upside
Reiterated
02/11/25
Exelixis: Buy Rating Backed by Strong Financial Performance, Promising Drug Pipeline, and Positive Risk/Reward Profile1:22 AM EXELIXIS (NASDAQ: EXEL) Buy (1) ESG $38.00 (Prior $34.00) SOLID Q4 BEAT; EXPECTING EXEL TO STAY INDEPENDENT AS PIPELINE IS OVERLOOKED THE TD COWEN INSIGHT EXEL reported Q4 revenues of $567M (+5% q/q) vs our $544M/cons $565M est. Cabo posted $513M vs our $495M/cons $504M. FY25 guidance of $1.95-$2.05B (+8-14% y/y) does not incl NET (4/3/25 PDUFA). We anticipate solid cabo NET launch and model $2.07B. Zanza has multiple data including Ph3 CRC ('25) and Ph3 nccRCC PFS & Ph2 HNSCC (H2:25). We anticipate EXEL staying independent. Pipeline is overlooked. Solid Q4; Expecting Solid Cabo NET Launch (4/3/25 PDUFA) – Many Ph3 Zanza & Q4 revs driven by +11% y/y cabo growth. Q4 non-GAAP EPS $0.55 beat our $0.49 and cons $0.45 ests.
Wells Fargo
$36
Buy
2.59%
Upside
Reiterated
02/11/25
Exelixis (EXEL) Receives a Buy from Wells Fargo
Bank of America Securities
$39
Hold
11.14%
Upside
Reiterated
02/11/25
Hold Rating on Exelixis Amid Uncertainty in Key Pipeline Asset and Market Opportunities
Leerink Partners
$32
Hold
-8.81%
Downside
Reiterated
02/11/25
Exelixis Hold Rating Maintained Amidst Stable Financials and Awaited Trial Data
Best Analysts Covering Exelixis
Which Analyst Should I Follow If I Want to Buy EXEL and Sell After:
1 Month
xxx
Success Rate
14/23 ratings generated profit
Average Return
+8.97%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.87% of your transactions generating a profit, with an average return of +8.97% per trade.
3 Months
xxx
Success Rate
19/23 ratings generated profit
Average Return
+27.67%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 82.61% of your transactions generating a profit, with an average return of +27.67% per trade.
1 Year
Success Rate
27/32 ratings generated profit
Average Return
+24.68%
reiterated a buy rating 10 days ago
Copying Silvan Tuerkcan's trades and holding each position for 1 Year would result in 84.38% of your transactions generating a profit, with an average return of +24.68% per trade.
2 Years
xxx
Success Rate
20/23 ratings generated profit
Average Return
+45.88%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 86.96% of your transactions generating a profit, with an average return of +45.88% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
EXEL Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
0
0
0
0
0
Buy
37
29
25
19
28
Hold
15
14
15
17
20
Sell
2
1
1
0
0
Strong Sell
0
0
0
0
0
total
54
44
41
36
48
Each month's total comprises the sum of three months' worth of ratings.
EXEL Financial Forecast
EXEL Stock Forecast FAQ
What is EXEL’s average 12-month price target, according to analysts?
Based on analyst ratings, Exelixis’s 12-month average price target is $37.47.
What is EXEL’s upside potential, based on the analysts’ average price target?
Exelixis has 6.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is EXEL a Buy, Sell or Hold?
Exelixis has a consensus rating of Moderate Buy which is based on 12 buy ratings, 8 hold ratings and 0 sell ratings.
What is Exelixis’s price target?
The average price target for Exelixis is $37.47. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $45.00 ,the lowest forecast is $29.00. The average price target represents 6.78% Increase from the current price of $35.09.
The highest analyst price target is $45.00 ,the lowest forecast is $29.00. The average price target represents 6.78% Increase from the current price of $35.09.
What do analysts say about Exelixis?
Exelixis’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.
How can I buy shares of EXEL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.